Establishment of reference interval for the detection of 31 kinds of acyl carnitines in newborns by non-derivatized derivative tandem mass spectrometry

BI Yan-jing, LI Yuan-yuan, TAN Meng-liang, SUN Yuan-yuan

Anhui Journal of Preventive Medicine ›› 2021, Vol. 27 ›› Issue (5) : 343-345.

PDF(792 KB)
PDF(792 KB)
Anhui Journal of Preventive Medicine ›› 2021, Vol. 27 ›› Issue (5) : 343-345. DOI: 10.19837/j.cnki.ahyf.2021.05.003

Establishment of reference interval for the detection of 31 kinds of acyl carnitines in newborns by non-derivatized derivative tandem mass spectrometry

  • BI Yan-jing, LI Yuan-yuan, TAN Meng-liang, SUN Yuan-yuan
Author information +
History +

Abstract

Objective To establish the reference interval of 31 kinds of acyl carnitines in the dry blood filter paper of Xuancheng newborn infants to provide diagnostic basis for the clinical diagnosis of fatty acid and organic acid genetic metabolic diseases. Methods 6093 newborn infants’ filter paper dried blood samples were selected from January to June in 2020 in Xuancheng City.The levels of 31 kinds of acyl carnitines were determined by non-derivatized tandem mass spectrometry.Statistical analysis was performed by SPSS 22.0 software.A single sample Kolmogorov-Smirnov test was used to judge the normality of the data.The percentile method was used to formulate the reference interval,and the 99.5th percentile value and the 0.5th percentile value were selected as the upper and lower limits of the cut-off value. Results The 31 kinds of acylcarnitine in Xuancheng City were non-normal distributed,and the reference intervals P0.5~P99.5 were (μmol/L) : free carnitine (9.11-48.60),acetylcarnitine (4.01-37.12),propionyl carnitine (0.54-4.30),malonyl carnitine (0.03-0.27),butyl carnitine (0.10-0.46),methyl propionyl carnitine (0.09-0.38),isovaleryl carnitine (0.05-0.36),methyl crotonyl carnitine (0.00-0.01),glutaric carnitine (0.05-0.19),hexyl carnitine (0.01-0.09),hexanoyl carnitine (0.03-0.30),octanoyl carnitine (0.02-0.14),octenyl carnitine (0.05-0.28),decanoyl carnitine (0.02-0.21),decenoyl carnitine (0.02-0.14),decenediacyl carnitine (0.00-0.03),dodecyl carnitine (0.02-0.23),dodecyl carnitine Alkali (0.01-0.17),tetradecanoyl carnitine (0.06-0.34),tetradecenoyl carnitine (0.03-0.21),tetradecadienoyl carnitine (0.01-0.04),3-hydroxytetradecyl carnitine (0.00-0.03),cetyl carnitine (0.71-6.14),cetenoyl carnitine (0.03-0.36),3-hydroxycetenoyl carnitine (0.01-0.10),3-hydroxycetanoyl carnitine (0.01-0.04),octadecanoyl carnitine (0.28-1.62),octadecenoyl carnitine (0.49-2.45),3-hydroxyoctadecenoyl carnitine (0.01-0.03),octadecdienoyl carnitine (0.06-0.53),3-hydroxyoctadecanoyl carnitine (0.00-0.02). Conclusion The reference interval of 31 kinds of acyl carnitines in neonatal filter paper dry blood tablets in Xuancheng City was established by non-derivatived tandem mass spectrometry,which can provide diagnostic reference basis for clinical diagnosis of fatty acid and organic acid genetic metabolic diseases in this area,and is more conducive to population screening of neonatal genetic metabolic diseases.

Key words

Neonatal / Non-derivatized / Acyl carnitine / Reference range interval

Cite this article

Download Citations
BI Yan-jing, LI Yuan-yuan, TAN Meng-liang, SUN Yuan-yuan. Establishment of reference interval for the detection of 31 kinds of acyl carnitines in newborns by non-derivatized derivative tandem mass spectrometry[J]. Anhui Journal of Preventive Medicine. 2021, 27(5): 343-345 https://doi.org/10.19837/j.cnki.ahyf.2021.05.003

References

[1] CLSI.Newborn screening for preterm,low birth weight,and sick newborns;Approved guideline.CLSI document I/LA31-A[S].Wayne,PA:Clinical and Laboratory Standards Institute,2009.
[2] CLSI.Newborn screening by Tandem mass spectrometry;Approved
guideline.CLSI document I/LA32-A[S].Wayne,PA:Clinical andLaboratory Standards Institute,2010.
[3] 国家卫生健康委员会临床检验中心新生儿遗传代谢病筛查室间质评委员会.新生儿遗传代谢病筛查指标切值建立方法专家共识[J].中国实用儿科杂志,2019,34(11):881-884.
[4] 中华人民共和国卫生部.新生儿疾病筛查管理办法[J].中华儿科杂志,2009,47(9):672-672.
[5] ISBN 1-56238-406-6.How to Define and Determine Reference Intervals in the Clinical Laboratory;Approved Guideline Second Edition,C28-A2[S].Clinical and Laboratory Standards Institue,2000.
[6] 赵正言,顾学范.新生儿遗传代谢病筛查[M].2版。北京:人民卫生出版社,2015:1-246.
[7] 蔡娜,谢云,马晓萍,等.串联质谱技术在新生儿遗传代谢病筛查中的临床应用研究[J].现代生物医学进展,2017,17(31):6083-6087.
[8] M Lindner.GF Hoffmann,D Matern.Newborn screening for disorders of fatty-acid oxidation:experience and recommendations from an expert meeting[J].J Inherit Metab Dis,2010,33(5):521-526.
[9] Moyer V A,Calonge N,Teutsch S M,et al.Expanding newborn screening:process,policy,and priorities[J].Hastings Cent Rep,2008,38(3):601-605.
[10] 刘芙蓉,王兴,孙小红,等.甘肃省正常新生儿干血斑氨基酸及酰基肉碱串联质谱检测指标医学参考范围的调查[J].现代检验医学杂志,2018,(3):31-37.
[11] 李淑红,毛新梅,沈丹,等.宁夏地区新生儿遗传代谢病串联质谱切值的建立[J].中国儿童保健杂志,2018,26(8):878-881.
PDF(792 KB)

Accesses

Citation

Detail

Sections
Recommended

/